Also the mid-term trend charts of the stocks that make up the portfolio are presented. ___
Comments on the chart:
* This week the portfolio's price closed +1.2% higher.
* The price met the resistance of the 30d SMA and retreated but now stands over the 9d SMA.
* The "head and shoulders" pattern scenario seems to weaken and now the most probable is the rising scenario.
* It's very likely that the very next days the portfolio's price may cross upwards the 30d SMA and reach the resistance of the 50d SMA.
* Notice that the MACD indicator gives a buy signal.
* We are entering into a state of Green Alert that is, we are getting ready to buy back the stocks that will cross upwards their 30d SMA and will stay over for 2 or 3 days, applying strictly all the rules of the post "You can't beat the market".
* The overall market sentiment seems to be changing to positive and we need to adapt quickly. An assessment of the picture of all the key market indexes, can be found in my post entitled "The indexes seem to be recovering from the fall".
* This HERCULES' portfolio analysis and all the previous ones, apply to all the portfolios with popular Nasdaq stocks and the new traders should follow these analyses, because they are an application of the method described in my post "You can't beat the market", until they don't need these analyses anymore because they'll do their own.
Next follows my post "The indexes seem to be recovering from the fall"
Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile.
Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.